EDGC launches early cancer detection technology brand ONCOCATCH
Posted : 2021-05-27 17:09
Updated : 2021-05-27 17:59
From left, EDGC s Co-CEOs Shin Sang-cheol and Lee Min-seob, Chief Medical Officer Kim Geong-cheol and healthcare business team leader Cho Sung-min during the company s ONCOCATCH brand launch webinar on May 23 / Courtesy of EDGC
By Ko Dong-hwan
The Korean genetic sequencing firm Eone Diagnomics Genome Center (EDGC) has launched an official brand for its advanced early cancer detection technology, paving the way for exports of the service to enter markets in and outside the country.
The company based in Incheon s Songdo held a webinar on May 23 to launch ONCOCATCH, a liquid biopsy-based technology. The brand s name comes from oncology.
EDGC to provide early cancer detection services to Europe working with Ukraine-based clinic
Posted : 2021-01-28 17:59
Updated : 2021-01-28 17:59
EDGC s co-CEO Lee Min-seob, second from left, speaks at the 2019 Kyiv International Economic Forum in Kiev, Ukraine. Courtesy of EDGC
By Ko Dong-hwan
South Korean genome research company Eone Diagnomics Genome Center (EDGC) said it will start providing early cancer detection services to Europe working with a Ukraine-based clinic that is participating in its research.
Working with PB MEDICOM-IN, based in Dnipro, the Ukraine, EDGC will for the first time in Europe provide two types of liquid biopsy services for cancer diagnosis, according to EDGC, Jan. 26. The two companies have conducted clinical trials for the services for about a year.